Sproxil
PrivateLast Round
Grant
Apr 30, 2025
Total Funding Raised
$1.86M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Sproxil operates in Enterprise Software and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Grant round in April 2025.
Sproxil is a technology company that provides a product verification platform used for brand protection, consumer engagement, and supply chain traceability to combat counterfeit goods.
Sector
Enterprise Software
Verticals
Supply Chain Tracking, Pharma Supply Chain, Supply Chain, Compliance & Risk, Customer Experience
Business Model
B2B2C
Customer Profile
Usage-Based SaaS, Subscription SaaS, Data as a Service, Government Contracts, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sproxil Comparables
Compare Sproxil with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| mPedigree | 93% | |
| PharmaSecure | 88% | |
| Chekkit Technologies | 84% |
For institutional investors. Book with your work email.
Sproxil Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 30, 2025 | ||||
| Grant | Nov 1, 2024 | ||||
| Grant | Oct 1, 2023 | ||||
| VC Round | Mar 22, 2011 | ||||
| Grant | Jan 1, 2010 | ||||
Grant | Feb 14, 2009 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Sproxil Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| USAID | Grant |
| Bill & Melinda Gates Foundation | Grant |
| Acumen | VC Round |
| Investing in Innovation (i3) Africa | Grant |
| Clinton Global Initiative University | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 89, 4x the trailing average.
- Jan 21, 2026
Grew 19% QoQ, from 64 to 76 employees.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withOct 2, 2026
Sproxil and Pharmacy Council of Nigeria partner through a memorandum of collaboration covering the National Electronic Pharmacy Platform, online medicine-sales oversight, digital field audits, and pharmacist professional development in Nigeria.
For institutional investors. Book with your work email.
Sproxil Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Sproxil's valuation, stock price, and market status.
Is Sproxil a public or private company?
Sproxil is a private company.
What is the current stock price of Sproxil?
Sproxil is a private company, so its shares have no public market price. Caplight tracks Sproxil's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Sproxil worth (valuation)?
Valuation information for Sproxil is not publicly available.
Can I buy Sproxil stock?
Sproxil shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Sproxil's last funding round?
Sproxil's most recent funding round was Grant on April 30, 2025.
Who are the main investors in Sproxil?
Key investors in Sproxil include Acumen.
Will Sproxil IPO soon?
No public IPO plans have been announced for Sproxil.
How can I track Sproxil secondary market activity?
Caplight tracks bids, offers, and trades in Sproxil's shares on secondary markets.